Sun Pharma and Takeda sign agreement to introduce Voltapraz in India
The agreement grants Sun Pharma non-exclusive patent licensing rights to market Vonoprazan tablets, available in 10 mg and 20 mg dosages, in India21-06-2024
21-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma signing non-exclusive patent licensing agreement with Takeda for Vonoprazan in India.21-06-2024
Sun Pharma receives warning letter from USFDA for Dadra facility
Letter lists violations of Current Good Manufacturing Practice regulations by the facility20-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Dadra Facility Receives Warning Letter From US FDA
Intimation regarding Warning Letter from US FDA19-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of 32Nd Annual General Meeting And Connected Matters
Friday, July 12, 2024 is fixed as the Record Date for Payment of Final Dividend for FY 2023-24.19-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of 32Nd Annual General Meeting And Connected Matters
Intimation of 32nd Annual General Meeting and Connected Matters19-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issuance of letter of confirmation in lieu of share certificates.18-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a SIngle Injection of MM-II in Patients with Painful Knee Osteoarthritis (OA)14-06-2024
Sun Pharma - Specialty To Drive Future Growth: Nirmal Bang
FY24 revenue increased by 10.4% to Rs 477,585 million, with improved gross margin and a rise in market share from 8.3% to 8.5%.14-06-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates.13-06-2024